By Colin Kellaher


Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain.

Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time.

The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output.

Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks.


Write to Colin Kellaher at colin.kellaher@wsj.com


(END) Dow Jones Newswires

04-26-24 0856ET